Presentation EuroPCR 2013 4EVER Trial: 1 Year Results Presenter: Marc Bosiers May 21, 2013 REGISTER for free or LOG IN to view this content Endovascular Presentation EuroPCR 2013 Up Next Presentation Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-fibfib Presenter: Sean van Diepen June 10, 2013 More slides + Presentation TCT 2012 Bifurcation and Left Main Disease: Technical Approaches to Optimize Long-term Outcomes Presenter: Philippe Garot October 22, 2012 Presentation TCT 2012 Complete vs. Incomplete Revascularization: Impact on Outcomes and Implications for Strategy Presenter: Giora Weisz October 22, 2012 We Recommend
Presentation Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-fibfib Presenter: Sean van Diepen June 10, 2013
Presentation TCT 2012 Bifurcation and Left Main Disease: Technical Approaches to Optimize Long-term Outcomes Presenter: Philippe Garot October 22, 2012
Presentation TCT 2012 Complete vs. Incomplete Revascularization: Impact on Outcomes and Implications for Strategy Presenter: Giora Weisz October 22, 2012